Global API Market Forecast to 2017

DUBLIN, August 9, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/92hzrx/global_api_market) have announced the addition of the "Global API Market Forecast to 2017" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The market for Active Pharmaceutical Ingredients is brimming with activities. While it is consolidating in US and EU resulting in the emergence of few big players producing specialty APIs that target high value markets, new players are entering in the mass markets of India and China. With global healthcare spending to have reached around US$ 6.4 trillion in 2010 and a rapidly ageing population boosting the demand for pharmaceuticals, APIs represent one of the most exciting markets for growth.

In their latest research study, "Global API Market Forecast to 2017", the authors identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 113 billion in 2012, is expected to grow at a CAGR of around 8% during 2012-2017.

For our study, we have analyzed the global API market from different perspectives. It has been studied at the Captive vs. Merchant level; Branded vs. Generic level and Synthetic vs. Biotech level. This has been done to provide a thorough and apt assessment to players who can use the research findings to support their business strategies.

At the regional level, the authors have provided a thorough understanding of the merchant API markets along with their future outlook to 2017. Each region's market is unique with exports playing a major role in regions of India and China. Each region's regulatory environment has also been elaborated, while discussing various drivers and challenges, to help new entrants overcome entry barriers. The report also provides a comparative analysis of key regions highlighting labor cost and productivity; price structure with reference to manufacturing indicators of profit margins, raw materials and conversion costs; and investment incurred in plant setups. These research findings will aid international players to strategically expand their presence globally.

Companies Mentioned

- Aurobindo Pharma Limited
- BASF SE
- Boehringer Ingelheim GmbH
- Cambrex Corporation
- Cipla
- Daiichi Fine Chemicals
- Divis Laboratories Limited
- Dr Reddy's Laboratories
- Fabbrica Italiana Sintetici
- GlaxoSmithKline
- Lonza
- Pfizer CentreSource
- Ranbaxy Laboratories
- Royal DSM
- Teva Active Pharmaceutical Ingredients
- Zhejiang Hisun Pharmaceutical Co. Ltd.

For more information visit http://www.researchandmarkets.com/research/92hzrx/global_api_market

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices